Company profile
ADx NeuroSciences company profile
ADx NeuroSciences develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. ADx was founded in 2011 by 4 pioneers in biomarker development and Alzheimer’s disease research. They combine more than 45 years of knowledge and experience and presents an impressive track record developing superior, highly performant and unique diagnostic biomarkers. The ADx markers allow accurate diagnosis even before symptoms appear, provide valuable patient information and bridge the gap between disease and novel treatments. Both in vitro diagnostic companies..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Founded
- 2011-01-01
Headquarters
- Headquarters
- Ghislenghien, Wallonia, Belgium
- Postal code
- 9052
- Country code
- BE
- Continent
- Europe